Regression slope (95% confidence interval) for three-year changes in percent stenosis per nm increase in on-study LDL-peak diameter and per mmol/L increase LDL-cholesterol subfraction concentrations.

<p>Regression slope (95% confidence interval) for three-year changes in percent stenosis per nm increase in on-study LDL-peak diameter and per mmol/L increase LDL-cholesterol subfraction concentrations.</p

Baseline characteristics of study participants.

<p>Age and BMI are displayed as mean±SD, lipoproteins as means±SE</p

Odds ratio (95% confidence interval) for primary disease endpoints (coronary-related deaths, myocardial infarctions, stroke, revascularization for worsening ischemia) per a one standard deviation increment in on-study LDL-peak diameter and LDL-subclass concentrations.

<p>Logistic regression analyses adjusted for baseline age, sex, BMI, current smoking status. Effects are per standard deviation increase in the on-study LDL-peak diameter (8.050 nm), LDL-I (0.185 mmol/L), LDL-IIa (0.234 mmol/L), LDL-IIb (0.326 mmol/L), LDL-IIIa (0.328 mmol/L), LDL-IIIb (0.113 mmol/L), LDL-IVa (0.049 mmol/L), and LDL-IVb (0.039 mmol/L).</p

On-study and change from baseline plasma lipoprotein subfraction concentrations (95% confidence interval) by treatment assignment.

<p>On-study and change from baseline plasma lipoprotein subfraction concentrations (95% confidence interval) by treatment assignment.</p

Three-year change in percent stenosis by quartiles of LDL-IIIb cholesterol.

<p>Adjusted for age, sex, BMI and smoking, and additional variables as indicated. Adjustment for lipids includes on-study HDL- and LDL-cholesterol and triglyceride concentrations. ^* designates significance relative to the first quartile at P<0.05.</p